KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 127 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $80,000 | -10.1% | 23,650 | 0.0% | 0.01% | -21.4% |
| Q2 2018 | $89,000 | -8.2% | 23,650 | 0.0% | 0.01% | -6.7% |
| Q1 2018 | $97,000 | -11.8% | 23,650 | 0.0% | 0.02% | -11.8% |
| Q4 2017 | $110,000 | -34.5% | 23,650 | 0.0% | 0.02% | -43.3% |
| Q3 2017 | $168,000 | -1.8% | 23,650 | 0.0% | 0.03% | 0.0% |
| Q2 2017 | $171,000 | +17.1% | 23,650 | 0.0% | 0.03% | +15.4% |
| Q1 2017 | $146,000 | -2.0% | 23,650 | -7.3% | 0.03% | -13.3% |
| Q4 2016 | $149,000 | +10.4% | 25,500 | 0.0% | 0.03% | -3.2% |
| Q3 2016 | $135,000 | – | 25,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |